

Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
Current price $0.574
Latest analyst grade actions
434 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 21.77 | Oscillator | Buy |
| Stochastic %K (14, 3, 3) | 7.36 | Oscillator | Buy |
| Williams %R (14) | -90.63 | Oscillator | Buy |
| MACD (12, 26, 9) | -0.38 (Hist -0.22) | Oscillator | Strong Sell |
| Average Directional Index (14) | 26.63 (+DI 11.4 / -DI 46.0) | Trend | Strong Sell |
| EMA 20 | 1.68 | MA | Strong Sell |
| SMA 20 | 1.94 | MA | Strong Sell |
| EMA 50 | 1.88 | MA | Strong Sell |
| SMA 50 | 2.13 | MA | Strong Sell |
| SMA 200 | 1.58 | MA | Strong Sell |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Dec 30, 25 | Dial Gerald | director | P-Purchase | 10,000 @ $0.762 | $7.62K |
| Mar 20, 26 | Croyle David J | 10 percent owner, officer: Chief Medical Officer | P-Purchase | 10,195 @ $1.75 | $17.84K |
| Mar 6, 26 | Croyle David J | 10 percent owner, officer: Chief Medical Officer | P-Purchase | 14,805 @ $1.76 | $26.09K |
| Feb 4, 25 | Dial Gerald | director | A-Award | 25,000 | — |
| Dec 30, 25 | Dial Gerald | director | P-Purchase | 1,539 @ $1.20 | $1.85K |
| Dec 30, 25 | Dial Gerald | director | P-Purchase | 461 @ $1.22 | $562 |
| Dec 16, 25 | Williams Wayne D | director, 10 percent owner, officer: CEO, Chairman and President | P-Purchase | 5,000 @ $1.73 | $8.65K |
| Dec 12, 25 | Williams Wayne D | director, 10 percent owner, officer: CEO, Chairman and President | P-Purchase | 4,926 @ $1.75 | $8.62K |
TTM vs. 5-year historical average (annual ratios)
| Metric | CJMB | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | -0.3x | 1.8x · sector 18.4x | Discount |
| Forward P/E | — | — | n/a |
| Price / Book | 4.8x | 2.3x | Elevated |
| Price / Sales | 0.5x | 1.2x | Discount |
| EV / EBITDA | -0.4x | 1.0x | Discount |
| Return on equity | -444.9% | — | Weak |
| Gross margin | 39.9% | 40.0% | In line |
| Debt / Equity | 3.14 | 0.31 | Levered |
| Piotroski / Altman Z | 3/9 | Z -10.16 | Distress |
Discounted cash flow model
Stock news · updated daily
The non-dilutive $16 million capital investment from a third party for Atlas Complex construction advances Callan JMB's pharmaceutical manufacturing strategy and strengthens its role in U.S. healthcare supply-chain preparedness SPRING BRANCH, Texas, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ: CJMB) (“Callan JMB” or the “Company”), a diversified preparedness, logistics, and critical-infrastructure company, today is providing shareholders with a timeline to break ground on an intravenous (IV) bag manufacturing and distribution facility at the Atlas Complex in Marion, Alabama. The $16 million facility will be fully funded by a third party through a non-dilutive, non-interest-bearing partnership.
Planned $16 million facility at the Atlas Complex advances Callan JMB's pharmaceutical manufacturing strategy and strengthens its role in U.S. healthcare supply-chain preparedness SPRING BRANCH, Texas, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ: CJMB) (“Callan JMB” or the “Company”), a diversified preparedness, logistics, and critical-infrastructure company, today announced formal approval of blueprints for the planned $16 million intravenous (IV) bag manufacturing and distribution facility at the Atlas Complex in Marion, Alabama. Once in production, the facility is projected to generate $450 million in annual revenue, including $300 million from standard IV bags and $150 million from premixed drug IV bags.
Approximately $28 million in planned TRUKING equipment advances domestic manufacturing capacity, strengthens the Company's preparedness strategy, and supports new commercial opportunities
Acquisition includes interests across 377 producing wells, approximately 150 BOE/day of current net production, and 27 additional wells in process, with $48 million of proved PV-10 and an illustrative 21% unlevered cash return at $75 WTI 1
Weigman brings 14 years of Williston Basin experience, including nine years at Northern Oil and Gas, and has sourced potential acquisition opportunities across more than 900 wells The appointment will reunite Weigman with Callan Power President Mike Reger, with whom he worked for nearly a decade at Northern Oil and Gas SPRING BRANCH, Texas, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Callan JMB, Inc. (Nasdaq: CJMB) (“Callan JMB” or the “Company”), a diversified company focused on logistics, emergency preparedness, and critical infrastructure, today announced that Callan Power will designate Andy Weigman as Senior Vice President of Land and Acquisitions upon closing of the previously announced asset acquisition from Reger Oil, Inc. Mr. Weigman will be responsible for Callan Power's s oil and gas land, operations, and acquisition functions.
Mr. Reger brings proven public-company, capital-markets, and energy-sector leadership to advance Callan Power's domestic manufacturing and critical electrical-infrastructure strategy
Program projected to generate approximately $252 million in cumulative net operating cash flow 23-well Red River drilling program forecast to achieve positive operating cash flow in its first year of drilling and generate approximately $42 million in annual net operating cash flow by 2029 SPRING BRANCH, Texas and Wayzata, Minn., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ: CJMB) (“Callan JMB” or the “Company”), a diversified company focused on logistics, emergency preparedness and critical infrastructure, today announced that Callan Power LLC (“Callan Power”), a wholly owned subsidiary of Callan JMB, has entered into a definitive agreement to acquire certain oil and gas assets from Reger Oil, Inc. (“Reger Oil”) related to the development of the Williston Basin energy reserves.
SPRING BRANCH, Texas, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (“Callan JMB” or the “Company”) (Nasdaq: CJMB) a diversified company focused on logistics, emergency preparedness and critical infrastructure, today announced that on August 14, 2026, it received written notification from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) confirming that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share (the “Minimum Bid Price Requirement”). The matter is now closed.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Aug 14, 2026 | — | -0.22 | — | $1.38M |
| May 15, 2026 | — | -0.59 | — | $1.11M |
| Mar 31, 2026 | — | -0.56 | — | $1.16M |
| Nov 14, 2025 | — | -0.61 | — | $1.45M |
| Aug 14, 2025 | — | -0.31 | — | $1.67M |
| May 15, 2025 | — | -0.32 | — | $1.35M |
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| POS AM | Oct 20, 2026 | 2026-10-20 14:10:49 | View |
| 8-K | Oct 19, 2026 | 2026-10-19 08:10:17 | View |
| 8-K | Oct 16, 2026 | 2026-10-16 16:10:14 | View |
| DEF 14C | Oct 2, 2026 | 2026-10-01 18:05:40 | View |
| POS AM | Sep 16, 2026 | 2026-09-16 14:53:48 | View |
| PRER14C | Sep 11, 2026 | 2026-09-11 12:59:34 | View |
| 8-K | Sep 1, 2026 | 2026-09-01 16:15:24 | View |
| 8-K | Aug 31, 2026 | 2026-08-31 16:30:46 | View |
| 8-K | Aug 24, 2026 | 2026-08-24 06:15:19 | View |
| 8-K | Aug 20, 2026 | 2026-08-20 06:02:02 | View |
Proxy statement (DEF 14A) disclosures